See other companies on Welcome to the Jungle
Salient
Lab operations & diagnostic services
- 1-20 employees
- Healthcare
- B2C
- B2B
- Robotics
- Biology
- Science
- Bermondsey, London, UK
Jump to section
Company mission
Salient's mission is to deliver a world class diagnostics service and experience to everyone.
Our take
Salient designs and creates automated, high-throughput, ultra-low-cost molecular diagnostics platforms for a range of medical conditions, with the ultimate goal to facilitate early intervention and improve overall health outcomes.
The company's first commercial offering was a COVID-19 PCR antigen testing kit rolled out during the pandemic, that provided guaranteed next-day results from nasal swabs and saliva samples. In 2022, it followed this up with the launch of its STI and Blood Testing capabilities, with its next target being non-seasonal bacterial and fungal infections. Alongside this, Salient will look to develop an offering based on Next Generation Sequencing (NGS) technologies, with a particular focus on microbiome diagnostics.
Salient's impressive team is made up of multidisciplinary experts with a combined 70+ years of experience researching synthetic biology and systems automation. Its accuracy, fast delivery, and cost-effectiveness make Salient’s modular diagnostics platform ideal for sectors that require a safe environment for regular human contact, such as logistics, facilities management, education and manufacturing.
Kirsty
Company Specialist at Welcome to the Jungle
Leadership
Marta Ciechonska
(Co-Founder)PhD in Microbiology and Immunology and experience in research at Imperial College London and the London Biofoundry.
Jack Priestman
(Co-Founder)Background in corporate development and business strategy at fintech startup Habito and in private equity investment.